These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1954966)

  • 1. Percutaneous caffeine application in the treatment of neonatal apnoea.
    Amato M; Isenschmid M; Hüppi P
    Eur J Pediatr; 1991 Jun; 150(8):592-4. PubMed ID: 1954966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental aspects of percutaneous caffeine absorption in premature infants.
    Amato M; Hüppi P; Isenschmid M; Schneider H
    Am J Perinatol; 1992; 9(5-6):431-4. PubMed ID: 1418150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
    Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
    Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise?
    Natarajan G; Botica ML; Thomas R; Aranda JV
    Pediatrics; 2007 May; 119(5):936-40. PubMed ID: 17473094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
    Yu T; Balch AH; Ward RM; Korgenski EK; Sherwin CM
    BMC Pharmacol Toxicol; 2016 Jun; 17(1):22. PubMed ID: 27266401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
    Zhao Y; Tian X; Liu G
    Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
    Koch G; Datta AN; Jost K; Schulzke SM; van den Anker J; Pfister M
    J Pediatr; 2017 Dec; 191():50-56.e1. PubMed ID: 29173321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine in apnoeic Asian neonates: a sparse data analysis.
    Lee HS; Khoo YM; Chirino-Barcelo Y; Tan KL; Ong D
    Br J Clin Pharmacol; 2002 Jul; 54(1):31-7. PubMed ID: 12100222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine citrate: a review of its use in apnoea of prematurity.
    Comer AM; Perry CM; Figgitt DP
    Paediatr Drugs; 2001; 3(1):61-79. PubMed ID: 11220405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral versus intramuscular loading of caffeine in idiopathic apnoea of prematurity.
    Cattarossi L; Colacino V; Janes A; LoGreco P; Rubini S; Zilli M; Macagno F
    Eur J Pediatr; 1988 Dec; 148(3):262-3. PubMed ID: 3063532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periextubation caffeine in preterm neonates: a randomized dose response trial.
    Steer PA; Flenady VJ; Shearman A; Lee TC; Tudehope DI; Charles BG
    J Paediatr Child Health; 2003; 39(7):511-5. PubMed ID: 12969204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of percutaneous caffeine in the treatment of apnea in the premature infant].
    Morisot C; Simoens C; Trublin F; Lhermitte M; Gremillet C; Robert MH; Lequien P
    Arch Fr Pediatr; 1990 Mar; 47(3):221-4. PubMed ID: 2344252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between plasma and urinary caffeine levels in preterm infants.
    Cattarossi L; Violino M; Macagno F; Logreco P; Savoia M
    J Perinat Med; 2006; 34(4):344-6. PubMed ID: 16856829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.
    He X; Qiu JC; Lu KY; Guo HL; Li L; Jia WW; Ni MM; Liu Y; Xu J; Chen F; Cheng R
    Adv Ther; 2021 Jan; 38(1):607-626. PubMed ID: 33180318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity.
    Lee TC; Charles B; Steer P; Flenady V; Shearman A
    Clin Pharmacol Ther; 1997 Jun; 61(6):628-40. PubMed ID: 9209245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
    Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
    JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of caffeine on pneumogram and apnoea of infancy.
    Anwar M; Mondestin H; Mojica N; Novo R; Graff M; Hiatt M; Hegyi T
    Arch Dis Child; 1986 Sep; 61(9):891-5. PubMed ID: 3767418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine or theophylline for neonatal apnoea?
    Scanlon JE; Chin KC; Morgan ME; Durbin GM; Hale KA; Brown SS
    Arch Dis Child; 1992 Apr; 67(4 Spec No):425-8. PubMed ID: 1586184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
    Zhang X; Zhang HT; Lyu Y; Wang LF; Yang ZY
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jun; 21(6):558-561. PubMed ID: 31208509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.